Consensus LeMaitre Vascular, Inc.

Stocks

LMAT

US5255582018

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 16:00:00 2026-09-11 EDT			5-day change	1st Jan Change
80.59 ^USD	+2.27%		-0.10%	-0.63%

08-06	Barrington Upgrades LeMaitre Vascular to Outperform From Market Perform, Price Target is $95	MT
08-05	Barrington Downgrades LeMaitre Vascular to Market Perform From Outperform	MT

Evolution of the Average Target: LeMaitre Vascular, Inc.

Evolution of the Target Price: LeMaitre Vascular, Inc.

Changes in Analyst Recommendations: LeMaitre Vascular, Inc.

7b6.YggFtgPhelvpwaYbnOvyvoLzJkKrFx3UXpqai1xA39c.AW1jzneCQ2KDiJV1_ruGhrCRXgufQ2_lEv3-yWkNh-MpTnP4dphJH5yZlg~85cd9a308b3245b6dffa962bd99cb136

Analysts' recommendations: LeMaitre Vascular, Inc.

08-06	Barrington Upgrades LeMaitre Vascular to Outperform From Market Perform, Price Target is $95	MT
08-05	Barrington Downgrades LeMaitre Vascular to Market Perform From Outperform	MT
05-06	Barrington Adjusts Price Target on LeMaitre Vascular to $120 From $105, Maintains Outperform Rating	MT
02-26	LeMaitre Vascular Shares Rise After Barrington Price Target Boost, Q4 Results	MT
02-26	Barrington Adjusts Price Target on LeMaitre Vascular to $105 From $95, Maintains Outperform Rating	MT
25-08-05	Medical device firm LeMaitre Q2 sales beat expectations	RE
25-02-28	Oppenheimer Downgrades LeMaitre Vascular to Market Perform From Overweight, Price Target is $45	MT
25-02-13	Wells Fargo Initiates LeMaitre Vascular at Equalweight With $95 Price Target	MT
24-10-15	Cantor Fitzgerald Initiates LeMaitre Vascular at Neutral With $96 Price Target	MT
24-05-31	Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target	MT
24-05-03	Barrington Boosts Price Target on LeMaitre Vascular to $79 From $69, Keeps Outperform Rating	MT
24-04-26	Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59	MT
24-02-28	Barrington Raises Price Target on LeMaitre Vascular to $69 From $66, Keeps Outperform Rating	MT
23-10-23	JMP Securities Initiates LeMaitre Vascular With Market Outperform Rating, Price Target is $60	MT
23-09-06	Oppenheimer Initiates Coverage on LeMaitre Vascular With Outperform Rating, $70 Price Target	MT
23-08-03	Jefferies Downgrades LeMaitre Vascular to Hold From Buy, Adjusts Price Target to $67 From $63	MT
23-08-02	Barrington Raises Price Target on LeMaitre Vascular to $66 From $62, Maintains Outperform Rating	MT
23-05-03	Stifel Raises LeMaitre Vascular's Price Target to $60 From $48, Hold Rating Kept	MT
23-05-03	Jefferies Raises LeMaitre Vascular's Price Target to $63 From $57, Maintains Buy Rating	MT
23-05-03	Roth MKM Raises LeMaitre Vascular's Price Target to $54 From $48, Neutral Rating Kept	MT
23-05-03	Barrington Research Upgrades LeMaitre Vascular to Outperform From Market Perform	MT
22-10-28	Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform	MT
22-04-29	Barrington Lowers LeMaitre Vascular's Price Target to $50 From $54, Maintains Outperform Rating	MT
22-02-25	Barrington Research Trims LeMaitre Vascular's Price Target to $54 From $62, Maintains Outperform Rating	MT
21-10-29	Barrington Adjusts Price Target on LeMaitre Vascular to $62 From $64, Maintains Outperform Rating	MT

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	LEMAITRE VASCULAR, INC.					+32.77%
	THERMO FISHER SCIENTIFIC, INC.					+5.79%
	DANAHER CORPORATION					+14.46%
	INTUITIVE SURGICAL, INC.					+29.04%
	BOSTON SCIENTIFIC CORPORATION					+45.22%
	SIEMENS HEALTHINEERS AG					+19.07%
	EDWARDS LIFESCIENCES CORPORATION					+19.67%
	AGILENT TECHNOLOGIES, INC.					+19.07%
	WATERS CORPORATION					+8.42%
	RESMED, INC.					+12.9%
	Average					+20.64%
	Weighted average by Cap.					+17.41%